Home

Applications

APPLICATIONS OVERVIEW
DRUG DISCOVERY
ADME-Tox
Biochemical Assays
Cell-based Assays
HTS and Secondary Screening
Microsampling
Protein Crystallography
RNAi
Sample Management
CANCER RESEARCH
Personalized Medicine
Functional Screening / DSRT
RNAi
Sequencing
Single-cell Genomics
GENOMIC RESEARCH
Gene Expression
Genotyping
Microbiome
qPCR
Sequencing
Single-cell Genomics
Synthetic Biology

Products

LIQUID HANDLING
LIQUID HANDLERS OVERVIEW
Echo® 525 Liquid Handler
Echo® 555 Liquid Handler
Echo® 550 Liquid Handler
Echo® 520 Liquid Handler
AUTOMATION
AUTOMATION OVERVIEW
Access™ Laboratory Workstation
Tempo™ Automation Control Software
SOFTWARE APPLICATIONS
SOFTWARE OVERVIEW
Echo® Array Maker
Echo® Cherry Pick
Echo® Combination Screen
Echo® Compliance Manager
Echo® Dose-Response
Echo® Plate Audit
Echo® Plate Reformat
CONSUMABLES
CONSUMABLES OVERVIEW
Echo® Qualified Microplates
Labcyte® Assay Microplates
MicroClime® Environmental Lid
Echo® Qualified Reservoir

Technology

Echo® Acoustic Liquid Handling
Dynamic Fluid Analysis™
Acoustic Mass Spectrometry
Direct Dilution

News / Events

Labcyte BLOG
Upcoming Events
Press Releases
Labcyte in the News
Labcyte Community

Resources

JALA Special Issue
Publications
Articles and Other Media
Application Notes
Posters
Webinars
Videos
Customer Profiles
Core Labs

Support

Brochures
Web Documentation*
User Guides*
Quick Start Guides*
Specification Sheets
Site Prep Guides
Service and Maintenance
Request Information

Company

About Us
Echo® Acoustic Technology
Leadership Team
Meet Labcyte
Careers
Contact and Location
Privacy Policy

Labcyte BLOG

Mendelspod Interviews Labcyte CEO on the Acoustic Liquid Handling Revolution
THURSDAY, FEBRUARY 16, 2017
linkedin twitter facebook |  30Shares

Our CEO Mark Fischer-Colbrie was interviewed on Mendelspod recently, talking about the revolution in liquid handling that has been made possible by the Echo acoustic liquid handling systems.


As host Theral Timpson points out in his introduction, people don’t usually think of liquid handling as enabling a life-saving drug or lowered drug prices, but by focusing on the most basic procedure in the lab – how scientists dispense their samples – Labcyte has had a very big impact.


By changing from traditional pipette dispensing to ejecting liquids using sound waves – which are reliably more accurate and repeatable – Labcyte’s acoustic technology transfers liquids with exquisite precision and accuracy at volumes as small as a billionth of a liter, says Fischer-Colbrie. From new drug discoveries, to repurposing of existing drugs, to creation of new diagnostics, the technology is having a direct impact at major pharmaceutical and diagnostics companies.


The technology is also being used to screen cancer patient cells for optimal treatments. The Institute for Molecular Medicine Finland was a pioneer in this work using the Echo, and talked about their experience on a previous Mendelspod episode. Fischer-Colbrie calls this “true personalized medicine.”


Additional applications in genomics and mass spec are generating excitement as well, in the case of synthetic biology shortening a 10-hour process down to 1 hour, and at 1/100th of the cost, says Fischer-Colbrie.
“You guys have defined a new era,” says Timpson.